7:45am | Welcome Steve Valiquette, U.S. Healthcare Services Senior Analyst, Barclays Presentation: Click here Replay Link: Click here |
8:00am | Presentation/ Fireside Chat: Pharmaceutical Marketplace Trends in 2018 Michael Kleinrock, Research Director, IQVIA Institute for Human Data Presentation: Click here Replay Link: Click here |
8:45am | Panel Discussion: Expert Perspectives on the Drug Pricing Debate The panel will discuss the current pricing environment and potential consequences of the ongoing political debate on pricing for pharma, PBMs and managed care, with the panel including: Jenny Bryant, SVP, Policy & Research, Pharmaceutical Research and Manufactures of America (PhRMA) Allen Dunehew, R.Ph. MPA, CEO, Rx Sourcing Strategies LLC: formerly Chief Procurement Officer, Express Scripts (ESRX) Mark Hamelburg, SVP, Federal Programs, America's Health Insurance Plans (AHIP) |
9:45am | Panel Discussion: Biotech/Specialty Pharmacy/ Biosimilars/Generic - Strategies, Opportunities & Reinbursement Shifts Allen Dunehew, R.Ph. MPA, CEO, Rx Sourcing Strategies LLC: formerly Chief Procurement Officer, Express Scripts (ESRX) Randy Falkenrath, VP, Specialty Strategy for Humana Pharmacy Solutions, Humana (HUM) Michael Kleinrock, Research Director, IQVIA Institute for Human Data Science (IQV) Ipsita Smolinski, MPH, Managing Director, Capital Street No presentation Replay Link: Click here |
10:45am | Panel Discussion: Healthcare Payors - Evolving Trends in Reimbursement and Policy Mark Hamelburg, SVP, Federal Programs, America's Health Insurance Plans (AHIP) James Scott, President & CEO, Applied Policy No presentation Replay Link: Click here |
11:15am | Panel Discussion: Healthcare Providers - Continued Shift in the Care Continuum (including implications for HCIT, Supply Channel and HC REITs) Lee H. Perlman, President, Greater New York Hospital Association (GNYHA) Ventures Mark Shaver, SVP of Strategy, Welltower James Scott, President & CEO, Applied Policy No presentation Replay Link: Click here |
Barclays is not responsible for the information or opinions contained any third-party audio or video presentations or any accompanying written or electronic materials (‘Third-Party Content’) that may be accessed via a hyperlink in this report. Any such Third-Party Content has not been adopted or endorsed by Barclays and does not represent the views or opinions of Barclays. Third-Party Content is provided for information purposes only and Barclays has not independently verified its accuracy. The inclusion in this report of hyperlinks to third-party websites does not imply any endorsement by or any affiliation with Barclays.